期刊文献+

强直性脊柱炎早期防治

Early Prevention and Treatment of Ankylosing Spondylitis
下载PDF
导出
摘要 目的探讨强直性脊柱炎的早期防治,提高诊断的准确性,减少致残率。方法回顾性分析我院2005年3月至2008年10月收治的强直性脊柱炎患者35例临床资料,分析其早期的临床症状、实验室检查结果及预后。结果观察组经治疗后总有效率为77.14%,对照组总有效率为57.14,2组疗效比较差异明显,P〈0.05。结论强直性脊柱炎早期诊断,早期治疗,对提高治愈率、降低致残率是十分重要的。 Objective Discusses the strong straight rachitis early preventing and controlling,enhances the diagnosis the accuracy,reduces cripples rate.Methods Retrospective analysis i homes March,2005toOctober,2008 received the strong direct of spinal meningitis patients 35 cases clinical information and analysis of its early clinical symptoms and laboratory test results and prognosis.Results After treatment,the total effective rate was 77.14%,total effective rate was 57.14 in control group,significant difference between the two groups,P0.05.Conclusion Early diagnosis of ankylosing spondylitis,early treatment,to improve the cure rate and reduce the morbidity is very important.
作者 林奋强
出处 《中外医疗》 2010年第23期24-25,共2页 China & Foreign Medical Treatment
关键词 强直性脊柱炎 早期防治 Ankylosing spondylitis Early prevention
  • 相关文献

参考文献4

二级参考文献16

  • 1侯勇,张奉春,黄烽,吴东海,鲍春德,倪立青,姚晨.Infliximab治疗类风湿关节炎的随机双盲平行多中心临床试验[J].中华风湿病学杂志,2006,10(11):658-663. 被引量:34
  • 2王莉莎,黄烽,张江林,邓小虎,张亚美,张莉芸,郭军华.肿瘤坏死因子拮抗剂在治疗强直性脊柱炎中的安全性分析[J].中国新药杂志,2007,16(7):556-561. 被引量:24
  • 3CHOY EH, PANAYI GS. Cytokine pathways and joint inflammation in rheumatoid arthritis[J]. N Engl J Med, 2001, 344(12): 907-916. 被引量:1
  • 4RIGBY WF. Drug insight: different mechanisms of action of tumor necrosis factor antagonists-passive-aggressive benavior? [J]. Nat Clin Pract Rheumatol, 2007, 3(2): 227-233. 被引量:1
  • 5SCALLON B, CAI A, SOLOWSKI N, et al. Binding and functional comparisons of two types of tumor necrosis factor antagonists[J]. J Pharmacol Exp Ther, 2002, 301 (2): 418-426. 被引量:1
  • 6St CLAIR EW, van DER HEIJDE DM, SMOLEN JS, et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial[J]. Arthritis Rheum, 2004, 50( 11 ) : 3432-3443. 被引量:1
  • 7GOEKOOP-RUITERMAN YP, de VRIES-BOUWSTRA JK, ALLAART CF, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study) : a randomized, controlled trial [J]. Arthritis Rheum, 2005, 52(11 ) : 3381-3390. 被引量:1
  • 8MAINI RN, BREEDVELD FC, KALDEN JR, et al. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate[J]. Arthritis Rheum, 2004, 50(4) : 1051-1065. 被引量:1
  • 9van DER BIJL AE, GOEKOOP-RUITERMAN YP, de VRIESBOUWSTRA JK, et al. Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis[J]. Arthritis Rheum, 2007, 56(7): 2129-2134. 被引量:1
  • 10van DER HEIJDE D, DIJKMANS B, GEUSENS P, et al. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT)[J]. Arthritis Rheum. 2005 Feb; 52(2): 582-591. 被引量:1

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部